Review articles
 

By Dr. Aisyah S Abdul Rahim , Mr. Muhamad Ikhwan Muhamad Sayuti , Mr. Kwek C Hau , Mr. Deffrey Chuah C Ee , Ms. Wan Nur Ruzaini Wan Zaki , Ms. Norliza Raskitar , Ms. Revathy Kanasin
Corresponding Author Dr. Aisyah S Abdul Rahim
Discipline of Pharmaceutical Chemistry School of Pharmaceutical Sciences Universiti Sains Malaysia, Universiti Sains Malaysia, Minden, Pulau Pinang - Malaysia - Malaysia 11800
Submitting Author Mr. Kwek C Hau
Other Authors Mr. Muhamad Ikhwan Muhamad Sayuti
School of Pharmaceutical Sciences Universiti Sains Malaysia, - Malaysia

Mr. Kwek C Hau
School of Pharmaceutical Sciences Universiti Sains Malaysia, Universiti Sains Malaysia, Minden, Pulau Pinang - Malaysia - Malaysia 11800

Mr. Deffrey Chuah C Ee
School of Pharmaceutical Sciences Universiti Sains Malaysia, - Malaysia

Ms. Wan Nur Ruzaini Wan Zaki
School of Pharmaceutical Sciences Universiti Sains Malaysia, - Malaysia

Ms. Norliza Raskitar
School of Pharmaceutical Sciences Universiti Sains Malaysia, - Malaysia

Ms. Revathy Kanasin
School of Pharmaceutical Sciences Universiti Sains Malaysia, - Malaysia

PHARMACEUTICAL SCIENCES

Aminoglycoside Streptomycin Neomycin Kanamycin Gentamycin

Abdul Rahim AS, Muhamad Sayuti M, Hau KC, Ee DC, Wan Zaki W, Raskitar N, et al. An Illustrated Review About Aminoglycosides. WebmedCentral PHARMACEUTICAL SCIENCES 2011;2(12):WMC002744
doi: 10.9754/journal.wmc.2011.002744

This is an open-access article distributed under the terms of the Creative Commons Attribution License(CC-BY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
No
Submitted on: 19 Dec 2011 01:24:31 PM GMT
Published on: 19 Dec 2011 03:31:23 PM GMT

Abstract


Aminoglycoside is a potent antibiotic that stops the protein synthesis continuation by binding to the ribosomal decoding site. They are used to treat infection caused by the aerobic, gram-negative and certain gram-positive organisms. The most commonly used aminoglycoside is Gentamicin. Generally, single daily dosing of aminoglycosides is appeared to be safer, cost effective and efficacious. Prolonged use of the drugs will lead to side effects such as ototoxicity and nephrotoxicity. Resistance towards aminoglycoside is possible but it rarely happens.  The structures activity relationship (SAR) of some aminoglycoside antibiotics is further reviewed in this paper.

Introduction


Aminoglycoside has been found 50 years ago and because of their excellent attainment, it was still used as a drug of choice to give various functions including rapid concentration-dependent bactericidal effect, synergism with beta-lactam antibiotics, clinical effectiveness, a low rate of true resistance and it is also low cost [1].
The first aminoglycoside found, streptomycin, was isolated from Streptomyces griseus in the year 1943 [2]. On the other hand, aminoglycosides that was usually given topically, neomycin,was isolated from Streptomyces fradiae, had better activity than streptomycin against aerobic gram-negative bacilli [2]. Gentamicin, was isolated from Micromonospora in the year 1963, was a breakthrough in the treatment of gram-negative bacillary infections, including those caused by Pseudomonas aeruginosa [2].
The aminoglycosides remain drugs of choice in treating many diseases including septicaemia, serious infections due to Gram negative bacilli, and bacterial endocarditis [1]. Streptomycin, the earlieast aminoglycosides found, is used to treat infections like tberculous meningitis, plague, brucellosis, and tularaemia. Tobramycin is used to treat serious bacterial infections caused by susceptible strains in lower respiratory tract which is an infection caused by bacteria P. Aerugionosa, Enterobater sp, E. Coli, Klebsiella sp, and S. Aureus[3] .Amikacin Sulphate Injection, USP is indicated in the short-term treatment of serious infections due to susceptible strains of gram-negative bacteria, including Pseudomonas sp, E. Coli, species of indole negative and indole positive Proteus, Providencia sp, Klebsiella-Enterobacter- Serratia sp, and Actinobacter sp. [4]

Classification and SAR of Aminoglycoside Antibiotics


Natural aminoglycoside antibiotics share a non-sugar 2-deoxystreptamine scaffold connected to amino sugar substituents at the 4-, 5- and 6-positions. The two most important classes of aminoglycoside antibiotics are the 4, 5- and 4, 6-disubstituted 2-deoxystreptamine derivatives. [5] The 4, 5-disubstituted 2-deoxystreptamine compounds include neomycin B whereas the 4,6-disubstituted 2 deoxystreptamine derivatives include gentamycin, kanamycin and streptomycin. Aminoglycoside antibiotics of these three groups, 4, 5- and 4, 6-disubstituted 2-DOS derivatives and apramycin, share in common a target site at the decoding center (A-site) of bacterial 16S ribosomal RNA (rRNA). 2-deoxystreptamine scaffold is the key pharmacophore required for the precise anchoring of the drugs at the RNA target. [6]
1. Streptomycin
Streptomycin is the first aminoglycoside antibiotic to be discovered and was the first antibiotic to be used in treatment of tuberculosis. It was discovered in 1943, in the laboratory of Selman Waksman at Rutgers University. Streptomycin is derived from the bacterium Streptomyces griseus.It inhibits bacterial growth by inhibiting protein synthesis. Specifically, it binds to the 16S rRNA of the bacterial ribosome, interfering with the binding of formyl-methionyl-tRNA to the 30S subunit.It is chemically stable and rapidly bactericidal, with a broad spectrum of inhibitory ctivity (apart from anaerobic bacteria).[7] Streptose, the central moiety, is a C-3-formyl derivative of 5-deoxy-Llyxose.[8] Two major precursors of the streptidine portion of the molecule have nowbeen defined, n-arginine and n-glucose (1, 2). [9]
2.Neomycin
Neomycin, an aminoglycoside antibiotic, discovered on 1949 in the lab of Selman Waksman.It has excellent activity against gram-negative bacteria, and has partial activity against gram-positive bacteria. It is produced naturally by the bacterium Streptomyces fradiae. Most potent aminoglycoside translation inhibitors [10].
3.Kanamycin
Kanamycin is made up of 3 rings. Ring II is sugar group,while ring I and III are non-sugar group. Kanamycin B is a more potent antibiotic than either kanamycins A or C. The presence of a diamino hexose, therefore, results in a compound that is a better inhibitor of protein synthesis than one containing only one amino group.Therefore, when only one amino group is present, an antibiotic that contains a 6-amino substituent is more active than one containing a 2-amino substituent.antibiotic activity can be related to the number and location of amino groups in the hexose moiety glycosidically linked to the 4-position of deoxystreptamine as follows (in decreasing order of potency): 2', 6'-diamino > 6'-amino > 2'-amino > no amino
4.Gentamicin
There have 3 types of gentamicin in this class of aminoglycosides such as Gentamicin C1, Gentamicin C2 and Gentamicin C1a. Gentamicin C1 exists when both R1 and R2 are CH3. Gentami cin C2 exists when R1 is CH3 and R2 is H. Gentamicin C1a exists when both R1 and R2 are H. The structure of gentamicin is consistent with the aminoglycoside structural activity relationship(SAR), except few minor changes. Gentamicin C1a binds in the major groove of the RNA.

Discussion


Illustration is a very useful method in explaining a particular matter with the use of only limited words. Images also produce a longer memory in our mind and it leads to the reason why we prefer to do an illustrated review on this topic.
In the beginning of our review, an illustration is used to explain the general uses of aminoglycosides and it shows exactly where the drugs should be applied to. Besides, several illustrations and structures have been used to illustrate the mechanism of action of aminoglycosides on the ribosomal subunit. This is to provide a more vivid idea on how a drug attaches to the specific part of the ribosomes and render the production of non-functional protein which eventually becomes detrimental to the bacteria. We also resort to the presentation of information in table form. It enables us to compare and contrast the spectrum of activity, clinical indication, pharmacokinetic and side effects of different types of aminoglycosides. By presenting all the information in a table, similarities and differences among them are more obvious as compared to explaining them in separate way. For examples, it is obviously depicted in the table that aminoglycosides are effective against both gram positive and gram negative bacteria.
Our visual memory is much more powerful than our audio memory. Converting a whole page of notes into pictures or illustrations ensures that we understand the information, we are summarising it and converting it into a picture. It will be so much easier to recall this picture from memory during an exam than to recall every word on a page of text. Using coloured pictures or illustrations to focus on main part of chemical structures stimulates our mind to remember the structure very well and its specifications. It acts as an instant guide for pharmacy students to read thoroughly and understand quickly during last minute revision or final preparations to avoid wasting time reading notes in a long essay form.
A structure with illustration used in explaining the structure relationship activity of aminoglycoside not only can facilitate the conceptualization and dissemination of information through it, but also motivate students to read it. With the important points fitted into each part of structure, it can help the students to interpret the structure more easily. They must be related to the text content with the structure of aminoglycoside because it is the nature of illustrations. As a result, they can know clearly about the function of each part of structure rather than when we separate the point with the structure. This is because it will make them confused and it is more difficult to relate the text content with the structure. It is a tedious task for them to find out the points that correspond for each part of drug structure. This is correlated with research done by Russell N. Carney which stated that illustration improve students’ learning from text because they make the text more concentrated, concrete, coherent, comprehensible, correspondent and codable [19] . An illustration form of drug structure can have representation and interpretation function. The more difficult the text is to be understood, the more the illustration helps.
For an illustrated article, a striking colour also plays a major role in helping the reader to recall facts and information. As compared to the black and white sentences or diagrams, the coloured one will make it easier for someone to focus on what they have to memorize and vice versa. Normally we use a striking colour such as red and yellow to emphasize the keywords or main points and we are likely to retain the information and remember them better. Colour tends to be processed by the right side of the brain and by introducing the colour into the information, it will stimulates more of your brain than if you just using one colour. By using colour, it makes the article far more interesting to look at, therefore much more engaging to the emotions and stimulates senses at the same time. Coloured diagrams, tables or explanations are important especially if you are doing a tedious or difficult topic.
In our opinions, we think that aminoglycosides are very useful in fighting a wide range of disease-causing bacteria. In reality, they have been to treat urinary tract infection caused by E. coli and other bacteria. Furthermore, Streptomycin is being used as a first line agent in treating Tuberculosis disease which is caused by the Mycobacterium Tuberculosis. Most of them are given as intramuscular and intravenous injections. The only drug that can be taken orally in this class is the Neomycin due to its high toxicity if given parenterally.
All members of aminoglycoside family of drugs can be ototoxic and nephrotoxic. We think that the side effects and toxicity should not be a reason to state that a drug “should not be used”. It is a matter that whether the decision making on based on age, renal function and overall condition of the patient is done correctly. Obviously, gentamycin should not be used if a patient has a decreased renal function because it will lead to drug accumulation and increased toxicity.

Conclusion


The most important classes of aminoglycosides antibiotics are the 4, 5- and 4, 6-disubstituted 2-deoxystreptamine derivatives. Different aminoglycosides antibiotics possess different structures especially on the rings and the functional group. The differences in functional groups could be the contributing reasons to the variety of actions of different aminoglycosides antibiotics.
Two mechanisms of action involving the aminoglycosides antibiotic are by interfering with the translation by causing a misreading of the codons along the mRNA and by interfering with the translocation of tRNA from A-Site to P-site. Aminoglycosides have concentration-dependenet killing action active against the gram-negative bacilli. But, neomycin, kanamycin and gentamycin active against both gram positive and gram negative bacteria. Gentamycin is the most commonly used aminoglycosides. Aminoglycosides are not advised to be given orally because they are poorly absorbed in GIT. It is normally given via intravenous or intramuscular injection.
Aminoglycosides are very effective in treating patient with the gram negative bacteria. But, it can cause nephrotoxicity and ototoxicity and only be given when in the cases of serious gram-negative systemic infection. If it is given to the patient with renal failure, dose monitoring must be conducted to avoid serious side effects such as toxicity of aminoglycosides.

References


1.Begg EJ, Barclay ML, (1995). Aminoglycosides-50 years on. [Online], vol.39, no.6, pp.597, Abstract only. Available: PubMed Central. [Accessed 11 November 2011] .
2.Gonzalez LS, Spencer JP, (1998). Aminoglycosides: A Practical Review. [Online] Pennsylvania: The American Academy of Family Physicians. Available: http://www.aafp.org/afp/981115ap/gonzalez.html[Accessed 11 November 2011].
3.Drugs.com, (2005). Tobramycin. [online] Available at: http://www.drugs.com/pro/tobramycin.html [Accessed date: 11 November 2011]
4.Drugs.com, (2004). Amikacin. [online] Available at: http://www.drugs.com/pro/amikacin.html[Accessed date: 11 November 2011]
5.T.Hermann (2007). Aminoglycoside antibiotics: old drugs and new therapeutic approaches. Cellular and Molecular Life Sciences.Edtion 64, pp.1841 – 1852
6.Busscher, G. F., Rutjes, F. P. and van Delft, F. L. (2005). 2-Deoxystreptamine: central scaffold of aminoglycoside antibiotics.Chem. Rev. 105, pp.775 – 791.
7.Antibiotics used in the treatment of infectious disease. (2011).[ONLINE] Available at:http://textbookofbacteriology.net/themicrobialworld/antimicrobial.html [Accessed 07 November 2011]
8.Joseph Bruton, William H.Horner.(1966). Biosynthesis of Streptomycin (III. Origin of The carbon Atoms of Streptose). The Journal of Biological Chemistry. [ONLINE].Vol.24, pp. 3142-3146. Available from: http://www.jbc.org [Accessed 08 November 2011].
9.William H.Horner. (July 1964). Biosynthesis of Streptomycin (II.Myo-inositol, A Precursor of The Streptidine Moiety). The Journal of Biological Chemistry. [ONLINE].Vol 239, 2256-2258. Available from : http://www.jbc.org. [Accessed 08 November 2011].
10.Fang Zhao, Qiang Zhao, Kenneth F. Blount, Qing Han, Yitzhak Tor, and Thomas Hermann. (2005). Molecular Recognition of RNA by Neomycin and a Restricted Neomycin Derivative. Structural Biochemistry. [ONLINE]. Vol. 44, pp.5329 –5334. Available from : http://onlinelibrary.wiley.com/doi/10.1002/anie.200500903/full
11.Satoko Yoshizawa, Dominique Fourmy et al (1998) Structural origins of gentamicin antibiotic action. The EMBO Journal ,Vol 17, No.22, pp.6437-6448.
12.Mehta A., (2010). Mechanism of Action of Aminoglycosides, PharmaXChange.info. [online] Available at:http://pharmaxchange.info/press/2011/05/mechanism-of-action-of-aminoglycosides/[Accessed: 11 November 2011]
13.World Health Organization Geneva, (2001). WHO model prescribing information: drugs used in bacterial infection, pp.177.
14.Mingeot-Leclercq MP, Glupczynski Y, and Tulkens PM. (1999) Aminoglycosides: Activity and Resistance. Antimicrobial Agents and Chemotherapy. Vol. 43, pp.727-37.
15.Nikaido, H. and Vaara, M. (1985) Molecular basis of bacterial outer membrane permeability. Microbiol. Rev. 49, pp.1–32.
16.Hancock, R.E.W., Farmer, S.W., Li, Z. and Poole, K. (1991) Interaction of aminoglycosides with the outer membranes and purified lipopolysaccharide and OmpF porin of Escherichia coli. Antimicrob. Agents Chemother. Vol.35, pp.1309–1314.
17.Davies J., Wright G. D. (1997) Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. Vol.5, pp.234–240.
18.Kucers A, Crowe S, Grayson ML, and Hoy J, eds. (1997) The Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, and Antiviral Drugs, 5th edition, Oxford: Butterworth Heinemann, pp.452-457.
19.Russell N. Carney, Joel R. Levin (2002) Pictorial Illustrations Still Improve Students’Learning From Text, Educational Psychology Review, Vol. 14, No. 1.

Source(s) of Funding


none

Competing Interests


none

Disclaimer


This article has been downloaded from WebmedCentral. With our unique author driven post publication peer review, contents posted on this web portal do not undergo any prepublication peer or editorial review. It is completely the responsibility of the authors to ensure not only scientific and ethical standards of the manuscript but also its grammatical accuracy. Authors must ensure that they obtain all the necessary permissions before submitting any information that requires obtaining a consent or approval from a third party. Authors should also ensure not to submit any information which they do not have the copyright of or of which they have transferred the copyrights to a third party.
Contents on WebmedCentral are purely for biomedical researchers and scientists. They are not meant to cater to the needs of an individual patient. The web portal or any content(s) therein is neither designed to support, nor replace, the relationship that exists between a patient/site visitor and his/her physician. Your use of the WebmedCentral site and its contents is entirely at your own risk. We do not take any responsibility for any harm that you may suffer or inflict on a third person by following the contents of this website.

Reviews
1 review posted so far

Review response
Posted by Dr. Oliver Grundmann on 05 Mar 2012 05:31:05 PM GMT

Comments
0 comments posted so far

Please use this functionality to flag objectionable, inappropriate, inaccurate, and offensive content to WebmedCentral Team and the authors.

 

Author Comments
0 comments posted so far

 

What is article Popularity?

Article popularity is calculated by considering the scores: age of the article
Popularity = (P - 1) / (T + 2)^1.5
Where
P : points is the sum of individual scores, which includes article Views, Downloads, Reviews, Comments and their weightage

Scores   Weightage
Views Points X 1
Download Points X 2
Comment Points X 5
Review Points X 10
Points= sum(Views Points + Download Points + Comment Points + Review Points)
T : time since submission in hours.
P is subtracted by 1 to negate submitter's vote.
Age factor is (time since submission in hours plus two) to the power of 1.5.factor.

How Article Quality Works?

For each article Authors/Readers, Reviewers and WMC Editors can review/rate the articles. These ratings are used to determine Feedback Scores.

In most cases, article receive ratings in the range of 0 to 10. We calculate average of all the ratings and consider it as article quality.

Quality=Average(Authors/Readers Ratings + Reviewers Ratings + WMC Editor Ratings)